BIOLINERX     Print Page  Close Window

SEC filings
6-K
BIOLINERX LTD. filed this Form 6-K on 08/11/2016
Entire Document
 

 
BioLineRx Ltd.
CONDENSED CONSOLIDATED INTERIM CASH FLOW STATEMENTS
(UNAUDITED)

   
Six months ended June 30,
 
   
2015
   
2016
 
   
in USD thousands
 
             
CASH FLOWS - OPERATING ACTIVITIES
           
Comprehensive loss for the period
   
(9,121
)
   
(7,223
)
Adjustments required to reflect net cash used in operating activities (see appendix below)
   
1,976
     
(223
)
Net cash used in operating activities
   
(7,145
)
   
(7,446
)
                 
CASH FLOWS - INVESTING ACTIVITIES
               
Investments in short-term deposits
   
(39,184
)
   
(19,804
)
Maturities of short-term deposits
   
22,738
     
24,182
 
Maturities of restricted deposits
   
166
     
-
 
Purchase of property and equipment
   
(1,586
)
   
(164
)
Purchase of intangible assets
   
(7
)
   
(24
)
Net cash provided by (used in) investing activities
   
(17,873
)
   
4,190
 
                 
CASH FLOWS - FINANCING ACTIVITIES
               
Issuances of share capital, net
   
28,645
     
1,595
 
Repayments of bank loan
   
-
     
(48
)
Net cash provided by financing activities
   
28,645
     
1,547
 
                 
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
   
3,627
     
(1,709
)
CASH AND CASH EQUIVALENTS – BEGINNING OF PERIOD
   
5,790
     
5,544
 
EXCHANGE DIFFERENCES ON CASH AND CASH EQUIVALENTS
   
(13
)
   
42
 
CASH AND CASH EQUIVALENTS - END OF PERIOD
   
9,404
     
3,877
 
 
The accompanying notes are an integral part of the financial statements.

4